Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
NCT03216408 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 504
Last updated 2017-07-13
Summary
This clinical study evaluates the efficacy and safety of Neuronox compared with Botox in adults with moderate to severe glabellar lines.
Conditions
- Glabellar Lines
Interventions
- DRUG
-
Neuronox
- DRUG
Sponsors & Collaborators
-
Medy-Tox
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-30
- Primary Completion
- 2016-11-10
- Completion
- 2017-03-07
More Related Trials
-
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
NCT06174688 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
NCT05496335 ·Status: COMPLETED ·Phase: PHASE1
-
Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines
NCT04631588 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248867 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
NCT04830345 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line
NCT03908008 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
NCT05248880 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants
NCT06794866 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
NCT06937944 ·Status: RECRUITING ·Phase: PHASE3
-
Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
NCT06448676 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
NCT05013424 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
NCT04996810 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines
NCT04281095 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate AI-09 In Participants With Glabellar Lines
NCT07321834 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01485601 ·Status: COMPLETED ·Phase: PHASE2
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
NCT02677805 ·Status: COMPLETED ·Phase: PHASE3
-
A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
NCT06161246 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
NCT02493946 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines
NCT05743634 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
NCT05766683 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study Of BOTOX For The Treatment Of Glabellar Lines
NCT00408785 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines
NCT06481475 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
NCT05100199 ·Status: COMPLETED ·Phase: PHASE2
-
To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.
NCT04944953 ·Status: COMPLETED ·Phase: PHASE1